United States: PTAB Reiterates Prior Art Must Describe A Claimed Range With Sufficient Specificity To Support An Anticipation Rejection - Oblon, McClelland, Maier & Neustadt, L.L.P
On May 2, 2023, the Patent Trial and Appeal Board (PTAB) overturned a rejection of a claim directed to microparticles containing leuprolide...
Full Article